Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children
Background: Lopinavir/ritonavir ‘pellets’ were recently tentatively approved for licensing. We describe their acceptability for infants and children up to 48 weeks. <br/>Methods: CHAPAS-2 was a randomised, 2-period crossover trial comparing syrup and pellets in HIV-infected infants (n=19, grou...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
International Medical Press
2016
|